(Q70959212)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8584608%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

The effects of D1 (NNC 22-0215) and D2 (haloperidol) antagonists in a chronic double-blind placebo controlled trial in cebus monkeys (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8584608%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

1 reference

D E Casey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8584608%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 October 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8584608%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

number of pages

5

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8584608%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8584608%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8584608%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

289-293

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8584608%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02246065

15 October 2019

exact match

0 references

cites work

Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems

1 reference

12 December 2020

SCH 23390 and psychosis

1 reference

12 December 2020

Serotonergic aspects of acute extrapyramidal syndromes in nonhuman primates

1 reference

12 December 2020

Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists

1 reference

12 December 2020

Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors

1 reference

12 December 2020

Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans.

1 reference

12 December 2020

Effect of chronic treatment with NNC 756, a new D-1 receptor antagonist, or raclopride, a D-2 receptor antagonist, in drug-naive Cebus monkeys: dystonia, dyskinesia and D-1/D-2 supersensitivity

1 reference

12 December 2020

Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride

1 reference

12 December 2020

The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment

1 reference

12 December 2020

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

1 reference

12 December 2020

NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists

1 reference

12 December 2020

Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys

1 reference

12 December 2020

SCH 23390 dissociated from conventional neuroleptics in apomorphine climbing and primate acute dyskinesia models

1 reference

12 December 2020

Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia

1 reference

12 December 2020

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

1 reference

12 December 2020

Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity

1 reference

12 December 2020

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

12 December 2020

SCH 23390—The first selective dopamine D-1 antagonist

1 reference

12 December 2020

The reversal of extrapyramidal side effects with SCH 39166, a dopamine D1 receptor antagonist

1 reference

12 December 2020

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Extrapyramidal syndromes in nonhuman primates: typical and atypical neuroleptics

1 reference

12 December 2020

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride

1 reference

12 December 2020

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems

1 reference

12 December 2020

Lack of acute antipsychotic effect of Sch 23390, a selective dopamine D1 receptor antagonist

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02246065

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8584608%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference